ENTITY
Microport Cardioflow Medtech

Microport Cardioflow Medtech (2160 HK)

55
Analysis
Health CareChina
Microport Cardioflow Medtech Corporation develops and sells medical devices. The Company manufactures and sells vitaflow aortic valve system, alwide balloon catheter, and other products. Microport Cardioflow Medtech markets its products throughout China.
more
Refresh
27 Jan 2021 11:02

MicroPort CardioFlow: What You Have to Assume

We think that the proposed valuation for MicroPort CardioFlow's HKEX listing is pricey, but the business has very good momentum. We would take the...

Share
27 Jan 2021 09:08

Cardioflow (微创心通)  IPO: Limited Upside

We think the cornerstone line up is not the best for a healthcare listing and there's also a limited upside of 10% at the high end despite a strong...

Logo
283 Views
Share
26 Jan 2021 17:18

MicroPort CardioFlow IPO: Valuation Insights

MicroPort aims to raise total net proceeds of $290 million at the mid-point of the IPO price range of HK$11.10-12.20 per share. Overall, we think...

Logo
356 Views
Share
24 Jan 2021 10:20

MicroPort Cardioflow (微创心通) Pre-IPO: Thoughts on Valuation

We are taking a close look at the Microport Cardioflow’s valuation. We are of the view that the company’s fair value should be around USD 3.0 billion.

Logo
405 Views
Share
24 Jan 2021 09:14

ECM Weekly (24 January 2021) - Kuaishou, New Horizon Health, Indigo Paints, Home First Fin, IRFC

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
x